Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 906 entries
Sorted by: Best Match Show Resources per page
Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells.

Scientific reports

Tochigi H, Kajihara T, Mizuno Y, Mizuno Y, Tamaru S, Kamei Y, Okazaki Y, Brosens JJ, Ishihara O.
PMID: 28443632
Sci Rep. 2017 Apr 26;7:46591. doi: 10.1038/srep46591.

No abstract available.

Cite
Tochigi H, Kajihara T, Mizuno Y, et al. Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep. 2017;7:46591doi: 10.1038/srep46591.
Tochigi, H., Kajihara, T., Mizuno, Y., Mizuno, Y., Tamaru, S., Kamei, Y., Okazaki, Y., Brosens, J. J., & Ishihara, O. (2017). Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Scientific reports, 746591. https://doi.org/10.1038/srep46591
Tochigi, Hideno, et al. "Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells." Scientific reports vol. 7 (2017): 46591. doi: https://doi.org/10.1038/srep46591
Tochigi H, Kajihara T, Mizuno Y, Mizuno Y, Tamaru S, Kamei Y, Okazaki Y, Brosens JJ, Ishihara O. Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep. 2017 Apr 26;7:46591. doi: 10.1038/srep46591. PMID: 28443632; PMCID: PMC5405451.
Copy Download .nbib Format: NLM
Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Tanaka H, Yamaguchi T, Hachiya K, Hayashi M, Ogawa S, Nishibori H, Kamei S, Ishihara S, Matsuo M, Kellam SG.
PMID: 28951699
Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):477-481. doi: 10.1016/j.rpor.2017.08.009. Epub 2017 Sep 19.

AIM: To assess the changes in prostate size in patients with prostate cancer undergoing intensity-modulated radiation therapy (IMRT).BACKGROUND: The effect of size change produced by IMRT is not well known.MATERIALS AND METHODS: We enrolled 72 patients who received IMRT...

Cite
Tanaka H, Yamaguchi T, Hachiya K, et al. Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone. Rep Pract Oncol Radiother. 2017;22(6):477-481doi: 10.1016/j.rpor.2017.08.009.
Tanaka, H., Yamaguchi, T., Hachiya, K., Hayashi, M., Ogawa, S., Nishibori, H., Kamei, S., Ishihara, S., Matsuo, M., & Kellam, S. G. (2017). Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 22(6), 477-481. https://doi.org/10.1016/j.rpor.2017.08.009
Tanaka, Hidekazu, et al. "Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone." Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology vol. 22,6 (2017): 477-481. doi: https://doi.org/10.1016/j.rpor.2017.08.009
Tanaka H, Yamaguchi T, Hachiya K, Hayashi M, Ogawa S, Nishibori H, Kamei S, Ishihara S, Matsuo M, Kellam SG. Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone. Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):477-481. doi: 10.1016/j.rpor.2017.08.009. Epub 2017 Sep 19. PMID: 28951699; PMCID: PMC5607145.
Copy Download .nbib Format: NLM
Temporal lobe epilepsy associated with GAD autoimmunity.

Acta diabetologica

Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.
PMID: 27638303
Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08.

No abstract available.

Cite
Obata A, Kutoku Y, Sunada Y, et al. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2016;54(3):321-323doi: 10.1007/s00592-016-0910-9.
Obata, A., Kutoku, Y., Sunada, Y., Okauchi, S., Kimura, T., Hirukawa, H., Tanabe, A., Kinoshita, T., Kohara, K., Tatsumi, F., Shimoda, M., Kamei, S., Nakanishi, S., Mune, T., Kaku, K., & Kaneto, H. (2017). Temporal lobe epilepsy associated with GAD autoimmunity. Acta diabetologica, 54(3), 321-323. https://doi.org/10.1007/s00592-016-0910-9
Obata, Atsushi, et al. "Temporal lobe epilepsy associated with GAD autoimmunity." Acta diabetologica vol. 54,3 (2017): 321-323. doi: https://doi.org/10.1007/s00592-016-0910-9
Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08. PMID: 27638303; PMCID: PMC5329084.
Copy Download .nbib Format: NLM
A case of vasa previa diagnosed prenatally, and review of the literature.

Journal of medical ultrasonics (2001)

Komatsu A, Kozuma S, Yoshida S, Hyodo H, Yamashita T, Kamei Y, Fujii T, Taketani Y.
PMID: 27278338
J Med Ultrason (2001). 2011 Jan;38(1):41-5. doi: 10.1007/s10396-010-0287-2. Epub 2010 Oct 30.

The perinatal mortality rate of vasa previa is high if it is not prenatally diagnosed. In this report, a case of vasa previa diagnosed prenatally is presented. Antepartum hemorrhage at 24 weeks of gestation prompted a close investigation of...

Cite
Komatsu A, Kozuma S, Yoshida S, et al. A case of vasa previa diagnosed prenatally, and review of the literature. J Med Ultrason (2001). 2010;38(1):41-5doi: 10.1007/s10396-010-0287-2.
Komatsu, A., Kozuma, S., Yoshida, S., Hyodo, H., Yamashita, T., Kamei, Y., Fujii, T., & Taketani, Y. (2011). A case of vasa previa diagnosed prenatally, and review of the literature. Journal of medical ultrasonics (2001), 38(1), 41-5. https://doi.org/10.1007/s10396-010-0287-2
Komatsu, Atsushi, et al. "A case of vasa previa diagnosed prenatally, and review of the literature." Journal of medical ultrasonics (2001) vol. 38,1 (2011): 41-5. doi: https://doi.org/10.1007/s10396-010-0287-2
Komatsu A, Kozuma S, Yoshida S, Hyodo H, Yamashita T, Kamei Y, Fujii T, Taketani Y. A case of vasa previa diagnosed prenatally, and review of the literature. J Med Ultrason (2001). 2011 Jan;38(1):41-5. doi: 10.1007/s10396-010-0287-2. Epub 2010 Oct 30. PMID: 27278338.
Copy Download .nbib Format: NLM
Tissue elastography imaging of the uterine cervix during pregnancy.

Journal of medical ultrasonics (2001)

Yamaguchi S, Kamei Y, Kozuma S, Taketani Y.
PMID: 27278485
J Med Ultrason (2001). 2007 Dec;34(4):209-10. doi: 10.1007/s10396-007-0150-2. Epub 2007 Dec 14.

No abstract available.

Cite
Yamaguchi S, Kamei Y, Kozuma S, et al. Tissue elastography imaging of the uterine cervix during pregnancy. J Med Ultrason (2001). 2007;34(4):209-10doi: 10.1007/s10396-007-0150-2.
Yamaguchi, S., Kamei, Y., Kozuma, S., & Taketani, Y. (2007). Tissue elastography imaging of the uterine cervix during pregnancy. Journal of medical ultrasonics (2001), 34(4), 209-10. https://doi.org/10.1007/s10396-007-0150-2
Yamaguchi, Syun-Ichi, et al. "Tissue elastography imaging of the uterine cervix during pregnancy." Journal of medical ultrasonics (2001) vol. 34,4 (2007): 209-10. doi: https://doi.org/10.1007/s10396-007-0150-2
Yamaguchi S, Kamei Y, Kozuma S, Taketani Y. Tissue elastography imaging of the uterine cervix during pregnancy. J Med Ultrason (2001). 2007 Dec;34(4):209-10. doi: 10.1007/s10396-007-0150-2. Epub 2007 Dec 14. PMID: 27278485.
Copy Download .nbib Format: NLM
Short- and long-term outcomes of third liver transplantation at single centre.

Hepatology international

Kamei H, Al-Basheer M, Shum J, Bloch M, Alejandro RH, McAlister V, Wall W, Quan D.
PMID: 26201807
Hepatol Int. 2013 Jun;7(2):728-33. doi: 10.1007/s12072-012-9364-5. Epub 2012 Mar 14.

PURPOSE: Although three or more liver transplantation (LT)s in the same patient arouse not only medical but also ethical issues in the context of organ shortage, it is a fact that additional liver retransplantation (reLT) is the only lifesaving...

Cite
Kamei H, Al-Basheer M, Shum J, et al. Short- and long-term outcomes of third liver transplantation at single centre. Hepatol Int. 2012;7(2):728-33doi: 10.1007/s12072-012-9364-5.
Kamei, H., Al-Basheer, M., Shum, J., Bloch, M., Alejandro, R. H., McAlister, V., Wall, W., & Quan, D. (2013). Short- and long-term outcomes of third liver transplantation at single centre. Hepatology international, 7(2), 728-33. https://doi.org/10.1007/s12072-012-9364-5
Kamei, Hideya, et al. "Short- and long-term outcomes of third liver transplantation at single centre." Hepatology international vol. 7,2 (2013): 728-33. doi: https://doi.org/10.1007/s12072-012-9364-5
Kamei H, Al-Basheer M, Shum J, Bloch M, Alejandro RH, McAlister V, Wall W, Quan D. Short- and long-term outcomes of third liver transplantation at single centre. Hepatol Int. 2013 Jun;7(2):728-33. doi: 10.1007/s12072-012-9364-5. Epub 2012 Mar 14. PMID: 26201807.
Copy Download .nbib Format: NLM
Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs.

Hepatology international

Kamei H, Masuda S, Nakamura T, Ishigami M, Fujimoto Y, Ogura Y, Oike F, Takada Y, Hamajima N.
PMID: 26201930
Hepatol Int. 2013 Jul;7(3):916-22. doi: 10.1007/s12072-013-9443-2. Epub 2013 Jul 31.

PURPOSE: Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However,...

Cite
Kamei H, Masuda S, Nakamura T, et al. Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatol Int. 2013;7(3):916-22doi: 10.1007/s12072-013-9443-2.
Kamei, H., Masuda, S., Nakamura, T., Ishigami, M., Fujimoto, Y., Ogura, Y., Oike, F., Takada, Y., & Hamajima, N. (2013). Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatology international, 7(3), 916-22. https://doi.org/10.1007/s12072-013-9443-2
Kamei, Hideya, et al. "Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs." Hepatology international vol. 7,3 (2013): 916-22. doi: https://doi.org/10.1007/s12072-013-9443-2
Kamei H, Masuda S, Nakamura T, Ishigami M, Fujimoto Y, Ogura Y, Oike F, Takada Y, Hamajima N. Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatol Int. 2013 Jul;7(3):916-22. doi: 10.1007/s12072-013-9443-2. Epub 2013 Jul 31. PMID: 26201930.
Copy Download .nbib Format: NLM
Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus.

International journal of surgery case reports

Ishida H, Nakano T, Fujishima F, Kamei T, Taniyama Y, Sakurai T, Sato C, Fukutomi T, Kamiya K, Ozawa Y, Sasano H, Ohuchi N.
PMID: 26629851
Int J Surg Case Rep. 2015;17:151-4. doi: 10.1016/j.ijscr.2015.11.013. Epub 2015 Nov 26.

INTRODUCTION: Basaloid squamous cell carcinoma of the oesophagus (BSCCE) is a relatively rare variant of oesophageal malignancy. There are no established treatment strategies for pulmonary metastases of BSCCE.PRESENTATION OF CASE: A 72-year-old man underwent oesophagectomy and subsequently received a...

Cite
Ishida H, Nakano T, Fujishima F, et al. Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus. Int J Surg Case Rep. 2015;17:151-4doi: 10.1016/j.ijscr.2015.11.013.
Ishida, H., Nakano, T., Fujishima, F., Kamei, T., Taniyama, Y., Sakurai, T., Sato, C., Fukutomi, T., Kamiya, K., Ozawa, Y., Sasano, H., & Ohuchi, N. (2015). Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus. International journal of surgery case reports, 17151-4. https://doi.org/10.1016/j.ijscr.2015.11.013
Ishida, Hirotaka, et al. "Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus." International journal of surgery case reports vol. 17 (2015): 151-4. doi: https://doi.org/10.1016/j.ijscr.2015.11.013
Ishida H, Nakano T, Fujishima F, Kamei T, Taniyama Y, Sakurai T, Sato C, Fukutomi T, Kamiya K, Ozawa Y, Sasano H, Ohuchi N. Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus. Int J Surg Case Rep. 2015;17:151-4. doi: 10.1016/j.ijscr.2015.11.013. Epub 2015 Nov 26. PMID: 26629851; PMCID: PMC4701867.
Copy Download .nbib Format: NLM
ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis.

Cell reports

Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S.
PMID: 25683718
Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12.

Ataxia-telangiectasia (A-T) patients occasionally develop diabetes mellitus. However, only limited attempts have been made to gain insight into the molecular mechanism of diabetes mellitus development in A-T patients. We found that Atm

Cite
Takagi M, Uno H, Nishi R, et al. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015;10(6):957-967doi: 10.1016/j.celrep.2015.01.027.
Takagi, M., Uno, H., Nishi, R., Sugimoto, M., Hasegawa, S., Piao, J., Ihara, N., Kanai, S., Kakei, S., Tamura, Y., Suganami, T., Kamei, Y., Shimizu, T., Yasuda, A., Ogawa, Y., & Mizutani, S. (2015). ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell reports, 10(6), 957-967. https://doi.org/10.1016/j.celrep.2015.01.027
Takagi, Masatoshi, et al. "ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis." Cell reports vol. 10,6 (2015): 957-967. doi: https://doi.org/10.1016/j.celrep.2015.01.027
Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12. PMID: 25683718.
Copy Download .nbib Format: NLM
Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy.

Journal of current ophthalmology

Do JL, Olmos de Koo LC, Ameri H.
PMID: 28626824
J Curr Ophthalmol. 2017 Feb 17;29(2):133-135. doi: 10.1016/j.joco.2017.01.004. eCollection 2017 Jun.

PURPOSE: To describe an atypical case of chronic central serous chorioretinopathy (CSCR).METHODS: A 58-year-old man with longstanding, bilateral visual impairment was self-referred for a second opinion.RESULTS: Findings by direct ophthalmoscopy, optical coherence tomography, fluorescein angiography, and fundus autofluorescence (FAF)...

Cite
Do JL, Olmos de Koo LC, Ameri H. Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy. J Curr Ophthalmol. 2017;29(2):133-135doi: 10.1016/j.joco.2017.01.004.
Do, J. L., Olmos de Koo, L. C., & Ameri, H. (2017). Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy. Journal of current ophthalmology, 29(2), 133-135. https://doi.org/10.1016/j.joco.2017.01.004
Do, Jiun L, et al. "Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy." Journal of current ophthalmology vol. 29,2 (2017): 133-135. doi: https://doi.org/10.1016/j.joco.2017.01.004
Do JL, Olmos de Koo LC, Ameri H. Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy. J Curr Ophthalmol. 2017 Feb 17;29(2):133-135. doi: 10.1016/j.joco.2017.01.004. eCollection 2017 Jun. PMID: 28626824; PMCID: PMC5463008.
Copy Download .nbib Format: NLM
Is blue dye still required during sentinel lymph node biopsy for breast cancer?.

Ecancermedicalscience

Peek MC, Kovacs T, Baker R, Hamed H, Kothari A, Douek M.
PMID: 27729939
Ecancermedicalscience. 2016 Sep 19;10:674. doi: 10.3332/ecancer.2016.674. eCollection 2016.

BACKGROUND: In early breast cancer, the optimal technique for sentinel lymph node biopsy (SLNB) is the combined technique (radioisotope and Patent Blue V) which achieves high identification rates. Despite this, many centres have decided to stop using blue dye...

Cite
Peek MC, Kovacs T, Baker R, et al. Is blue dye still required during sentinel lymph node biopsy for breast cancer?. Ecancermedicalscience. 2016;10:674doi: 10.3332/ecancer.2016.674.
Peek, M. C., Kovacs, T., Baker, R., Hamed, H., Kothari, A., & Douek, M. (2016). Is blue dye still required during sentinel lymph node biopsy for breast cancer?. Ecancermedicalscience, 10674. https://doi.org/10.3332/ecancer.2016.674
Peek, Mirjam Cl, et al. "Is blue dye still required during sentinel lymph node biopsy for breast cancer?." Ecancermedicalscience vol. 10 (2016): 674. doi: https://doi.org/10.3332/ecancer.2016.674
Peek MC, Kovacs T, Baker R, Hamed H, Kothari A, Douek M. Is blue dye still required during sentinel lymph node biopsy for breast cancer?. Ecancermedicalscience. 2016 Sep 19;10:674. doi: 10.3332/ecancer.2016.674. eCollection 2016. PMID: 27729939; PMCID: PMC5045297.
Copy Download .nbib Format: NLM
LETTER TO THE EDITOR Excision of Congenital Bilateral Persistent Pupillary Membrane in a Child with Exotropia.

The open ophthalmology journal

Iida M, Mimura T, Goto M, Kamei Y, Kondo A, Saito Y, Okuma H, Matsubara M.
PMID: 25926901
Open Ophthalmol J. 2015 Mar 31;9:33-5. doi: 10.2174/1874364101509010033. eCollection 2015.

CASE REPORT: A 7-year-old boy presented with a persistent pupillary membrane in both eyes. His best corrected visual acuity (BCVA) was 20/20 in the right eye and 20/32 in the left eye with exotropia of 18 prism diopters. He...

Cite
Iida M, Mimura T, Goto M, et al. LETTER TO THE EDITOR Excision of Congenital Bilateral Persistent Pupillary Membrane in a Child with Exotropia. Open Ophthalmol J. 2015;9:33-5doi: 10.2174/1874364101509010033.
Iida, M., Mimura, T., Goto, M., Kamei, Y., Kondo, A., Saito, Y., Okuma, H., & Matsubara, M. (2015). LETTER TO THE EDITOR Excision of Congenital Bilateral Persistent Pupillary Membrane in a Child with Exotropia. The open ophthalmology journal, 933-5. https://doi.org/10.2174/1874364101509010033
Iida, Michiko, et al. "LETTER TO THE EDITOR Excision of Congenital Bilateral Persistent Pupillary Membrane in a Child with Exotropia." The open ophthalmology journal vol. 9 (2015): 33-5. doi: https://doi.org/10.2174/1874364101509010033
Iida M, Mimura T, Goto M, Kamei Y, Kondo A, Saito Y, Okuma H, Matsubara M. LETTER TO THE EDITOR Excision of Congenital Bilateral Persistent Pupillary Membrane in a Child with Exotropia. Open Ophthalmol J. 2015 Mar 31;9:33-5. doi: 10.2174/1874364101509010033. eCollection 2015. PMID: 25926901; PMCID: PMC4406997.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 906 entries